Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carina Heydt

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Cancer Cytopathology|September 5, 2020
Predictive molecular pathology of lung cancer in Germany with focus on gene fusion testing: Methods and quality assuranceJanna Siemanowski, Carina Heydt, Sabine Merkelbach-Bruse
The Journal of Pathology. Clinical Research|April 29, 2017
<i>KRAS</i> mutation in papillary fibroelastoma: a true cardiac neoplasm?Maike Wittersheim, Carina Heydt, Fabian Hoffmann, et al.
Cancers|June 10, 2023
Overview of Molecular Detection Technologies for Carina Heydt, Michaela Angelika Ihle, Sabine Merkelbach-Bruse
BMC Cancer|December 17, 2025
Genetic diversity in melanomagenesis: a comprehensive analysis of BRAF, NRAS, KIT and novel mutations across melanoma subtypesÖmer Fahrettin Göze, Reinhard Buettner, Margarete Odenthal, et al.
Oncotarget|April 11, 2018
Novel approaches against epidermal growth factor receptor tyrosine kinase inhibitor resistanceCarina Heydt, Sebastian Michels, Kenneth S Thress, et al.
Diagnostic Pathology|March 28, 2024
Concurrent KRAS p.G12C mutation and ANK3::RET fusion in a patient with metastatic colorectal cancer: a case reportTillmann Bedau, Carina Heydt, Udo Siebolts, et al.
Frontiers in Oncology|August 13, 2025
NGS coverage accurately predicts <i>MET</i> and <i>HER2</i> (<i>ERBB2</i>) gene amplifications in a real-world non-small cell lung cancer cohortAdam Kowalewski, Janna Siemanowski-Hrach, Thomas Stehle, et al.
Heliyon|December 27, 2023
Efficiency of B-RAF-/MEK-inhibitors in B-RAF mutated Ameloblastoma: Case report and review of literatureReinhard Büttner, Sibel Elif Gültekin, Carina Heydt, et al.
Expert Review of Molecular Diagnostics|January 30, 2016
The impact of sequencing on diagnosis and treatment of malignant melanomaRoberta Castiglione, Michaela A Ihle, Carina Heydt, et al.
Virchows Archiv : an International Journal of Pathology|February 2, 2018
The landscape of genetic alterations in ameloblastomas relates to clinical featuresSibel Elif Gültekin, Reem Aziz, Carina Heydt, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Cancer Cytopathology|September 5, 2020
Predictive molecular pathology of lung cancer in Germany with focus on gene fusion testing: Methods and quality assuranceJanna Siemanowski, Carina Heydt, Sabine Merkelbach-Bruse
The Journal of Pathology. Clinical Research|April 29, 2017
<i>KRAS</i> mutation in papillary fibroelastoma: a true cardiac neoplasm?Maike Wittersheim, Carina Heydt, Fabian Hoffmann, et al.
Cancers|June 10, 2023
Overview of Molecular Detection Technologies for Carina Heydt, Michaela Angelika Ihle, Sabine Merkelbach-Bruse
BMC Cancer|December 17, 2025
Genetic diversity in melanomagenesis: a comprehensive analysis of BRAF, NRAS, KIT and novel mutations across melanoma subtypesÖmer Fahrettin Göze, Reinhard Buettner, Margarete Odenthal, et al.
Oncotarget|April 11, 2018
Novel approaches against epidermal growth factor receptor tyrosine kinase inhibitor resistanceCarina Heydt, Sebastian Michels, Kenneth S Thress, et al.
Diagnostic Pathology|March 28, 2024
Concurrent KRAS p.G12C mutation and ANK3::RET fusion in a patient with metastatic colorectal cancer: a case reportTillmann Bedau, Carina Heydt, Udo Siebolts, et al.
Frontiers in Oncology|August 13, 2025
NGS coverage accurately predicts <i>MET</i> and <i>HER2</i> (<i>ERBB2</i>) gene amplifications in a real-world non-small cell lung cancer cohortAdam Kowalewski, Janna Siemanowski-Hrach, Thomas Stehle, et al.
Heliyon|December 27, 2023
Efficiency of B-RAF-/MEK-inhibitors in B-RAF mutated Ameloblastoma: Case report and review of literatureReinhard Büttner, Sibel Elif Gültekin, Carina Heydt, et al.
Expert Review of Molecular Diagnostics|January 30, 2016
The impact of sequencing on diagnosis and treatment of malignant melanomaRoberta Castiglione, Michaela A Ihle, Carina Heydt, et al.
Virchows Archiv : an International Journal of Pathology|February 2, 2018
The landscape of genetic alterations in ameloblastomas relates to clinical featuresSibel Elif Gültekin, Reem Aziz, Carina Heydt, et al.
Pageof 6